☆ 4.7 Article

Novel Biomarkers for Inflammatory Bowel Disease and Colorectal Cancer: An Interplay between Metabolic Dysregulation and Excessive Inflammation

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Related references

Note: Only part of the references are listed.

Review Nutrition & Dietetics

Should the Mediterranean diet be recommended for inflammatory bowel diseases patients? A narrative review

Alicja Ewa Ratajczak et al.

Summary: Inflammatory bowel diseases (IBD) are chronic inflammatory disorders of unknown cause. Diet, especially the Mediterranean diet (MD), may play a role in the development and progression of IBD. MD can enrich beneficial bacteria in the gut and improve gut barrier function, reducing inflammation. However, adherence to MD is generally low among IBD patients, and they may avoid certain MD components due to gastrointestinal symptoms. Patients should be encouraged to adopt a healthy and well-balanced diet based on their individual tolerance.

FRONTIERS IN NUTRITION (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Role of metformin in inflammation

Yu Yue Feng et al.

Summary: Metformin has anti-inflammatory effects and provides potential therapeutic targets for inflammatory diseases such as neuroinflammation and rheumatoid arthritis. Targeted inflammatory intervention is significant for both cancer prevention and treatment, as inflammation is a key component of tumor occurrence and development.

MOLECULAR BIOLOGY REPORTS (2023)

Add to Collection

Review Cell Biology

New insights into activation and function of the AMPK

Gregory R. Steinberg et al.

Summary: AMP-activated protein kinase (AMPK) is a cellular energy sensor that is activated by increases in AMP/ADP to ATP ratios. Recent studies have discovered non-canonical pathways for AMPK activation, involving calcium, nutrients, metabolites, DNA and lysosome damage. AMPK has been found to regulate carbohydrate and lipid metabolism, mitochondrial and lysosomal homeostasis, and DNA repair. Its role in cancer, obesity, diabetes, nonalcoholic steatohepatitis (NASH), and other disorders has been explored, suggesting potential therapeutic targets.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2023)

Add to Collection

Editorial Material Gastroenterology & Hepatology

Challenges in the Pathophysiology, Diagnosis, and Management of Intestinal Fibrosis in Inflammatory Bowel Disease

Geert D'Haens et al.

GASTROENTEROLOGY (2022)

Add to Collection

Review Gastroenterology & Hepatology

New Insights into the Role of Oral Microbiota Dysbiosis in the Pathogenesis of Inflammatory Bowel Disease

Ying Qi et al.

Summary: Inflammatory bowel disease (IBD) is a group of chronic intestinal inflammatory disorders characterized by genetic susceptibility, environmental triggers, and immune system disruption. Dysbiosis of the gut and oral microbiota may exacerbate IBD progression. Ectopic colonization of specific oral bacteria in the gut could lead to chronic intestinal inflammation in IBD patients.

DIGESTIVE DISEASES AND SCIENCES (2022)

Add to Collection

Article Immunology

The role of enteric dysbacteriosis and modulation of gut microbiota in the treatment of inflammatory bowel disease

Wei Niu et al.

Summary: The incidence of inflammatory bowel disease (IBD) is increasing globally and significantly impacts patients' quality of life. Imbalance in intestinal flora has been identified as a critical factor in the progression of IBD. Regulating the composition and function of the intestinal flora has emerged as a potential treatment strategy, with numerous experiments confirming the relationship between intestinal flora, immune regulation, and anti-inflammation.

MICROBIAL PATHOGENESIS (2022)

Add to Collection

Review Nutrition & Dietetics

Gut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease

Xue Guo et al.

Summary: Inflammatory bowel disease (IBD) is characterized by relapse and remission, making it challenging to diagnose and assess disease activity. Traditional biomarkers from plasma and stool lack specificity, while changes in gut microbiota are closely associated with IBD etiology and pathogenesis.

FRONTIERS IN NUTRITION (2022)

Add to Collection

Article Gastroenterology & Hepatology

Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management

Shailja C. Shah et al.

Summary: Patients with inflammatory bowel disease (IBD) have an increased risk of developing colorectal cancer (CRC). Chronic inflammation plays a key role in the development of neoplastic progression, resulting in dysplastic precursor lesions. Colitis-associated CRC shares molecular similarities with sporadic CRC and the microbiome and host immune system may also play a role. However, further research is needed to understand the specific molecular differences and their role in inflammation-associated cancers.

GASTROENTEROLOGY (2022)

Add to Collection

Review Gastroenterology & Hepatology

Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease

Sara Jarmakiewicz-Czaja et al.

Summary: The incidence of nonalcoholic fatty liver disease (NAFLD) is increasing each year. Inadequate lifestyle, disturbances in intestinal microbiome, and the use of certain drugs are common causes of NAFLD. Patients with inflammatory bowel disease (IBD) are also at a higher risk of developing NAFLD. Steroid use, particularly in the treatment of IBD, is a significant contributing factor to the development of NAFLD. Further research is needed to determine the dose and exposure time of steroids that may lead to the development of NAFLD.

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2022)

Add to Collection

Review Immunology

Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity

Tianhao Duan et al.

Summary: This article provides a detailed overview of the innate immune system's defense mechanisms against pathogens, with a focus on the role of Toll-like receptors (TLRs) in immune responses. TLRs not only link innate immunity to adaptive immunity, but also directly regulate the function of T cells. In addition, the article discusses the critical role of TLR signaling in host defense against infectious diseases, autoimmune diseases, and cancer.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Article Rheumatology

NOD/RIPK2 signalling pathway contributes to osteoarthritis susceptibility

Michael J. Jurynec et al.

Summary: Altered NOD/RIPK2 signaling pathway components are associated with familial OA. The disease allele Ripk2(104Asp) increases susceptibility to post-traumatic OA in mice.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Add to Collection

Review Immunology

Dysregulated inflammasome activity in intestinal inflammation - Insights from patients with very early onset IBD

David Illig et al.

Summary: Inflammatory bowel disease (IBD) is a disorder caused by imbalances of the microbiome and immune dysregulations. Multimeric inflammasomes play a critical role in regulating host defense and gut homeostasis. Excessive production of pro-inflammatory Interleukin-1 beta has been detected in IBD patients and associated with disease severity. Genome-wide association studies suggest that inflammasome components may be associated with IBD development.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Review Oncology

Cancer Immunotherapy: The Checkpoint between Chronic Colitis and Colorectal Cancer

Ramya Ephraim et al.

Summary: Inflammatory bowel disease (IBD) causes intestinal inflammation and lesions due to an abnormal immune response, with current treatments having limited long-term efficacy. Patients with chronic colitis are at a higher risk of developing colorectal cancer, highlighting the need for improved therapies. Cancer immunotherapy, particularly immune checkpoint inhibitors, has transformed cancer treatment and shown promising results in both single and combination therapies.

CANCERS (2022)

Add to Collection

Review Gastroenterology & Hepatology

The metabolic nature of inflammatory bowel diseases

Timon E. Adolph et al.

Summary: Experimental and clinical evidence support the role of metabolic perturbation in gut inflammation in IBD, which is linked to dietary factors. These studies also highlight the connection between metabolism and inflammation in IBD.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)

Add to Collection

Review Biochemistry & Molecular Biology

The Current Status of Molecular Biomarkers for Inflammatory Bowel Disease

Zahra Alghoul et al.

Summary: Diagnosis and prognosis of inflammatory bowel disease (IBD) are challenging due to the lack of a gold-standard test. Endoscopy and imaging, while essential, have limitations in terms of invasiveness and cost. Laboratory testing of blood or feces, although non-invasive and cost-effective, needs improvement in terms of specificity and accuracy. This review discusses non-invasive biomarkers for IBD testing and the trends and challenges in biomarker studies.

BIOMEDICINES (2022)

Add to Collection

Review Biology

AMPK and Diseases: State of the Art Regulation by AMPK-Targeting Molecules

Olga Tarasiuk et al.

Summary: This article discusses the activation mechanism and role of AMPK. AMPK is an enzyme that plays a key role in cellular energy homeostasis and metabolism, and is closely related to the occurrence and development of various diseases. It has been shown that compounds that mimic AMP activation of AMPK may be potential drugs for treating diseases. However, further research is needed to understand the mechanisms and effects of these compounds.

BIOLOGY-BASEL (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Etiology of IBD-Is It Still a Mystery?

Anna Kofla-Dlubacz et al.

Summary: Inflammatory bowel diseases (IBD), such as colitis ulcerosa and Crohn's disease, are chronic diseases of the gastrointestinal tract caused by a multifactorial etiology. The excessive immune system reaction due to interactions of environmental, microbiological, and genetic factors leads to chronic inflammation of the gastrointestinal walls. Understanding the pathogenic pathways allows for pharmacological modulation and effective treatment of these diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Review Immunology

Excessive intake of sugar: An accomplice of inflammation

Xiao Ma et al.

Summary: High sugar intake is recognized as a potential risk factor for non-communicable diseases and excessive consumption of hexoses can contribute to inflammation-related diseases.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Review Chemistry, Medicinal

Tackling Inflammatory Bowel Diseases: Targeting Proinflammatory Cytokines and Lymphocyte Homing

Yijie Song et al.

Summary: Inflammatory bowel diseases (IBDs) are chronic inflammatory disorders caused by abnormal immune response. The development of proinflammatory cytokine therapeutic agents, including TNF inhibitors, shows promise for treating IBD. Antagonizing other cytokines has shown advantages in clinical trials and can be used to target anti-TNF therapy failure. Additionally, blocking lymphocyte homing helps alleviate inflammation and tissue damage.

PHARMACEUTICALS (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Metformin in therapeutic applications in human diseases: its mechanism of action and clinical study

Yang Du et al.

Summary: Metformin is a commonly used first-line medication for type 2 diabetes due to its outstanding glucose-lowering ability. It exerts its effect through multiple mechanisms, including AMPK-dependent and AMPK-independent mechanisms. Clinical studies have shown that in addition to decreasing cardiovascular events and anti-obesity, metformin may also be beneficial for neurodegenerative disease, polycystic ovary syndrome, aging, cancer, and COVID-19, but it may also induce adverse effects.

MOLECULAR BIOMEDICINE (2022)

Add to Collection

Article Gastroenterology & Hepatology

Metformin Use Is Associated with a Lower Risk of Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus

Chin-Hsiao Tseng

Summary: The risk of developing inflammatory bowel disease is lower in patients with type 2 diabetes mellitus who have been treated with metformin, compared to those who have never used it.

JOURNAL OF CROHNS & COLITIS (2021)

Add to Collection

Article Gastroenterology & Hepatology

The four epidemiological stages in the global evolution of inflammatory bowel disease

Gilaad G. Kaplan et al.

Summary: The global burden of inflammatory bowel disease is evolving into four epidemiological stages: Emergence, Acceleration in Incidence, Compounding Prevalence, and Prevalence Equilibrium. Developing countries, newly industrialized countries, and Western regions are in different stages of disease evolution.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Add to Collection

Article Endocrinology & Metabolism

Peripheral and central regulation of insulin by the intestine and microbiome

Jonathan D. Schertzer et al.

Summary: The progression of type 2 diabetes disrupts the homeostasis of blood glucose and insulin, regulated by peripheral and central responses involving the intestine and microbiome. Gut-derived bacterial factors can promote inflammation and insulin resistance, while other postbiotics can increase insulin sensitivity. Understanding the molecular signaling in the intestine and the host-microbe relationship may provide new insights for targeting obesity, metabolic disease, and type 2 diabetes.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2021)

Add to Collection

Review Gastroenterology & Hepatology

Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational Risks from Mechanisms to Medicines

Ross J. Porter et al.

Summary: The cumulative impact of chronic inflammation in patients with inflammatory bowel diseases predisposes to the development of IBD-CRC. Inflammation can induce mutagenesis, and the molecular pathogenesis of IBD-CRC is well described, while the immunopathogenesis is less understood. The impact of novel immunosuppressive therapies on achieving deep remission in IBD-CRC remains mostly unknown.

JOURNAL OF CROHNS & COLITIS (2021)

Add to Collection

Review Developmental Biology

The regulation of Yorkie, YAP and TAZ: new insights into the Hippo pathway

Samuel A. Manning et al.

DEVELOPMENT (2020)

Add to Collection

Review Oncology

A Potential Role of YAP/TAZ in the Interplay Between Metastasis and Metabolic Alterations

Hirohito Yamaguchi et al.

FRONTIERS IN ONCOLOGY (2020)

Add to Collection

Article Biochemistry & Molecular Biology

A regulatory region on RIPK2 is required for XIAP binding and NOD signaling activity

Valentin J. Heim et al.

EMBO REPORTS (2020)

Add to Collection

Article Oncology

Insluin and epithelial growth factor (EGF) promote programmed death ligand 1(PD-L1) production and transport in colon cancer stem cells

Mingshui Chen et al.

BMC CANCER (2019)

Add to Collection

Review Cell Biology

RASSF1A, puppeteer of cellular homeostasis, fights tumorigenesis, and metastasis-an updated review

Fatemeh Dubois et al.

CELL DEATH & DISEASE (2019)

Add to Collection

Review Immunology

Toll-like receptors: Significance, ligands, signaling pathways, and functions in mammals

Mallenahally Kusha Vidya et al.

INTERNATIONAL REVIEWS OF IMMUNOLOGY (2018)

Add to Collection

Review Biochemistry & Molecular Biology

Tumor suppressor C-RASSF proteins

Hiroaki Iwasa et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2018)

Add to Collection

Article Pharmacology & Pharmacy

Identification and Characterization of Novel Receptor-Interacting Serine/Threonine-Protein Kinase 2 Inhibitors Using Structural Similarity Analysis

Mohamed Salla et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)

Add to Collection

Correction Oncology

RIPK2: New Elements in Modulating Inflammatory Breast Cancer Pathogenesis (vol 10, 184, 2018)

Alaa Zare et al.

CANCERS (2018)

Add to Collection

Review Dentistry, Oral Surgery & Medicine

Cancer metabolism: New insights into classic characteristics

Yasumasa Kato et al.

JAPANESE DENTAL SCIENCE REVIEW (2018)

Add to Collection

Article Chemistry, Medicinal

Identification of Potent and Selective RIPK2 Inhibitors for the Treatment of Inflammatory Diseases

Xiaohui He et al.

ACS MEDICINAL CHEMISTRY LETTERS (2017)

Add to Collection

Review Biochemistry & Molecular Biology

AMP-activated protein kinase: a therapeutic target in intestinal diseases

Xiaofei Sun et al.

OPEN BIOLOGY (2017)

Add to Collection

Review Oncology

Metformin and pancreatic cancer: Is there a role?

Andre De Souza et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)

Add to Collection

Article Oncology

RASSF1A Site-Specific Methylation Hotspots in Cancer and Correlation with RASSF1C and MOAP-1

Natalia Volodko et al.

CANCERS (2016)

Add to Collection

Article Oncology

A MYC-Driven Change in Mitochondrial Dynamics Limits YAP/TAZ Function in Mammary Epithelial Cells and Breast Cancer

Bjoern von Eyss et al.

CANCER CELL (2015)

Add to Collection

Article Gastroenterology & Hepatology

The global burden of IBD: from 2015 to 2025

Gilaad G. Kaplan

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)

Add to Collection

Review Endocrinology & Metabolism

AMPK: energy sensor and survival mechanism in the ischemic heart

Dake Qi et al.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)

Add to Collection

Article Gastroenterology & Hepatology

Colitis-associated colon cancer: Is it in your genes?

Lauren Van Der Kraak et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2015)

Add to Collection

Review Gastroenterology & Hepatology

Treatment of IBD: Where We Are and Where We Are Going

Charles N. Bernstein

AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)

Add to Collection

Article Oncology

Metformin for Primary Colorectal Cancer Prevention in Patients With Diabetes: A Case-Control Study in a US Population

Amikar Sehdev et al.

CANCER (2015)

Add to Collection

Review Biochemistry & Molecular Biology

RASSF tumor suppressor gene family: Biological functions and regulation

Natalia Volodko et al.

FEBS LETTERS (2014)

Add to Collection

Article Immunology

Hypoxic macrophages impair autophagy in epithelial cells through Wnt1: relevance in IBD

D. Ortiz-Masia et al.

MUCOSAL IMMUNOLOGY (2014)

Add to Collection

Article Multidisciplinary Sciences

Nod/Ripk2 signaling in dendritic cells activates IL-17A-secreting innate lymphoid cells and drives colitis in T-bet-/-.Rag2-/- (TRUC) mice

Joerg Ermann et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Add to Collection

Review Gastroenterology & Hepatology

Colorectal carcinogenesis-update and perspectives

Hans Raskov et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Add to Collection

Article Microbiology

Reactive Oxygen Species Regulate Caspase-11 Expression and Activation of the Non-canonical NLRP3 Inflammasome during Enteric Pathogen Infection

Christopher R. Lupfer et al.

PLOS PATHOGENS (2014)

Add to Collection

Review Medicine, General & Internal

Helminth therapy (worms) for induction of remission in inflammatory bowel disease

Sushil K. Garg et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)

Add to Collection

Review Oncology

The Hippo pathway in disease and therapy: cancer and beyond

Marta Gomez et al.

CLINICAL AND TRANSLATIONAL MEDICINE (2014)

Add to Collection

Review Biochemistry & Molecular Biology

Metabolic changes in cancer: beyond the Warburg effect

Weihua Wu et al.

ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2013)

Add to Collection

Article Biochemistry & Molecular Biology

TLR9 signaling defines distinct prognostic subsets in CLL

Dimitar G. Efremov et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2013)

Add to Collection

Review Cell Biology

RIP2 activity in inflammatory disease and implications for novel therapeutics

Janice C. Jun et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2013)

Add to Collection

Article Immunology

Receptor interacting protein kinase 2-mediated mitophagy regulates inflammasome activation during virus infection

Christopher Lupfer et al.

NATURE IMMUNOLOGY (2013)

Add to Collection

Article Multidisciplinary Sciences

The Tumor Suppressor Gene, RASSF1A, Is Essential for Protection against Inflammation -Induced Injury

Marilyn Gordon et al.

PLOS ONE (2013)

Add to Collection

Review Cell Biology

Targeting cellular metabolism to improve cancer therapeutics

Y. Zhao et al.

CELL DEATH & DISEASE (2013)

Add to Collection

Review Cell Biology

YAP oncogene overexpression supercharges colon cancer proliferation

Joseph Avruch et al.

CELL CYCLE (2012)

Add to Collection

Article Gastroenterology & Hepatology

Molecular pathways in colorectal cancer

Sam Al-Sohaily et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)

Add to Collection

Article Multidisciplinary Sciences

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

Luke Jostins et al.

NATURE (2012)

Add to Collection

Article Pharmacology & Pharmacy

AMPK agonist downregulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis

Aiping Bai et al.

BIOCHEMICAL PHARMACOLOGY (2010)

Add to Collection

Review Gastroenterology & Hepatology

Canadian Digestive Health Foundation Public Impact Series. Inflammatory bowel disease in Canada: Incidence, prevalence, and direct and indirect economic impact

Richard N. Fedorak et al.

CANADIAN JOURNAL OF GASTROENTEROLOGY (2010)

Add to Collection

Article Cell Biology

The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program

Jing Cai et al.

GENES & DEVELOPMENT (2010)

Add to Collection

Article Cell Biology

Inhibition of RIP2's tyrosine kinase activity limits NOD2-driven cytokine responses

Justine T. Tigno-Aranjuez et al.

GENES & DEVELOPMENT (2010)

Add to Collection

Article Pharmacology & Pharmacy

Novel Anti-Inflammatory Action of 5-Aminoimidazole-4-carboxamide Ribonucleoside with Protective Effect in Dextran Sulfate Sodium-Induced Acute and Chronic Colitis

Aiping Bai et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)

Add to Collection

Article Biochemistry & Molecular Biology

The RASSF8 candidate tumor suppressor inhibits cell growth and regulates the Wnt and NF-κB signaling pathways

F. E. Lock et al.

ONCOGENE (2010)

Add to Collection

Article Multidisciplinary Sciences

Hippo signaling regulates Drosophila intestine stem cell proliferation through multiple pathways

Fangfang Ren et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Add to Collection

Review Medicine, General & Internal

MECHANISMS OF DISEASE Inflammatory Bowel Disease

Clara Abraham et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Add to Collection

Article Biochemistry & Molecular Biology

The RASSF1A tumor suppressor restrains anaphase-promoting complex/cyclosome activity during the G1/S phase transition to promote cell cycle progression in human epithelial cells

Angelique W. Whitehurst et al.

MOLECULAR AND CELLULAR BIOLOGY (2008)

Add to Collection

Article Gastroenterology & Hepatology

Epithelial restitution and wound healing in inflammatory bowel disease

Andreas Sturm et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2008)

Add to Collection

Article Biochemistry & Molecular Biology

Skp2 regulates the antiproliferative function of the tumor suppressor RASSF1A via ubiquitin-mediated degradation at the G1-S transition

M. S. Song et al.

ONCOGENE (2008)

Add to Collection

Article Biochemistry & Molecular Biology

RASSF6 is a novel member of the RASSF family of tumor suppressors

N. P. C. Allen et al.

ONCOGENE (2007)

Add to Collection

Letter Cell Biology

The tumor suppressor RASSF1A does not interact with Cdc20, an activator of the anaphase-promoting complex

Limin Liu et al.

CELL CYCLE (2007)

Add to Collection

Article Gastroenterology & Hepatology

The epidemiology of inflammatory bowel disease in Canada: A population-based study

Charles N. Bernstein et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)

Add to Collection

Review Neurosciences

AMPK and cell proliferation - AMPK as a therapeutic target for atherosclerosis and cancer

Hiroyuki Motoshima et al.

JOURNAL OF PHYSIOLOGY-LONDON (2006)

Add to Collection

Article Biochemistry & Molecular Biology

The RASSF1A isoform of RASSF1 promotes microtubule stability and suppresses tumorigenesis

L van der Weyden et al.

MOLECULAR AND CELLULAR BIOLOGY (2005)

Add to Collection

Article Biochemistry & Molecular Biology

Local activation of Rap1 contributes to directional vascular endothelial cell migration accompanied by extension of microtubules on which RAPL, a Rap1-associating molecule, localizes

H Fujita et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

Add to Collection

Article Biochemistry & Molecular Biology

The centrosomal protein RAS association domain family protein 1A (RASSF1A)-binding protein 1 regulates mitotic progression by recruiting RASSF1A to spindle poles

MS Song et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

Add to Collection

Article Cell Biology

The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex

MS Song et al.

NATURE CELL BIOLOGY (2004)

Add to Collection

Review Cell Biology

Signaling to NF-κB

MS Hayden et al.

GENES & DEVELOPMENT (2004)

Add to Collection

Article Biochemistry & Molecular Biology

The pro-apoptotic Ras effector Nore1 may serve as a Ras-regulated tumor suppressor in the lung

MD Vos et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2003)

Add to Collection

Review Biochemistry & Molecular Biology

NF-κB as a therapeutic target in cancer

RZ Orlowski et al.

TRENDS IN MOLECULAR MEDICINE (2002)

Add to Collection

Article Nutrition & Dietetics

Insulin, insulin-like growth factors and colon cancer: A review of the evidence

E Giovannucci

JOURNAL OF NUTRITION (2001)

Add to Collection

© Peeref 2019-2024. All rights reserved.